Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
In 2023, North America dominated the market and held the largest share. Growth can be attributed to the rising prevalence of chronic diseases, genetic disorders, & infectious diseases, the increasing demand for rapid diagnostic tests, and the growing geriatric population.
Furthermore, significant investments in gene-based research and the presence of leading players, such as Thermo Fisher Scientific Bio-Rad Laboratoriesm & Agilent Technologies, have also positively influenced the market.
Another factor driving the growth post COVID-19 is technological advancements, such as microfluidic PCR in droplets, on- & off-chip thermocycling, and on-chip integration. For instance, in January 2021, Lexa Gene launched a microfluidic PCR device as an Emergency Use Authorization (EUA) test.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This continent databook contains high-level insights into North America real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account